Back to Search
RADEK BUKOWSKI, MD
MD
Maternal & Fetal Medicine Physician
NPI: 1922167352Individual
Specialties, Licenses & Credentials
Maternal & Fetal Medicine PhysicianPrimary
Obstetrics & Gynecology — Maternal & Fetal Medicine
Code: 207VM0101X
K8034(TX)
Research & Publications (20)
Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study.
PMID 17355993·BMJ·2007
4-observational
The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats.
PMID 11641685·Am J Obstet Gynecol·2001
4-observational
T-REX: software for the processing and analysis of T-RFLP data.
PMID 19500385·BMC Bioinformatics·2009
8-other
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.
PMID 19615940·Lancet Oncol·2009
3-trial
Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm.
PMID 19213661·Clin Genitourin Cancer·2009
8-other
Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study.
PMID 19434228·PLoS Med·2009
8-other
Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reports.
PMID 19430005·Ann Oncol·2009
5-case
Myeloid-derived suppressor cells: a novel therapeutic target.
PMID 19216839·Curr Oncol Rep·2009
6-review
Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.
PMID 19402064·Cancer·2009
8-other
Targeted Therapies: Bevacizumab and interferon-alpha in metastatic renal-cell carcinoma.
PMID 19390549·Nat Rev Clin Oncol·2009
8-other
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
PMID 19318484·Clin Cancer Res·2009
3-trial
Optical Gaussian beam interaction with one-dimensional thermal wave in the Raman-Nath configuration.
PMID 19252623·Appl Opt·2009
8-other
Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.
PMID 19276286·Clin Cancer Res·2009
8-other
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.
PMID 19451442·J Clin Oncol·2009
3-trial
Axitinib treatment in patients with cytokine-refractory metastatic renal cell cancer.
PMID 19216838·Curr Oncol Rep·2009
8-other
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
PMID 19487381·J Clin Oncol·2009
3-trial
Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independent.
PMID 19661301·Anticancer Res·2009
8-other
Prognostic factors for survival in metastatic renal cell carcinoma: update 2008.
PMID 19402065·Cancer·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1501 RED RIVER ST
AUSTIN, TX 78712 - Phone
- (512) 324-7000
Quick Facts
- NPI
- 1922167352
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile